modelD06AX12

Diagram of D06AX12

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Amikacin
ATC code:D06AX12
route:intravenous
compartments:2
dosage:500mg
volume of distribution:16.1L
clearance:4.3L/h
other parameters in model implementation

Amikacin is an aminoglycoside antibiotic used primarily for the treatment of severe bacterial infections caused by Gram-negative bacteria, including those resistant to other aminoglycosides. It is approved and commonly used today, mainly in hospital settings for serious infections such as sepsis, pneumonia, urinary tract infections, and intra-abdominal infections.

Pharmacokinetics

Pharmacokinetic parameters reported for adult patients with normal renal function receiving intravenous infusion.

References

  1. Severino, N, et al., & Paredes, N (2023). Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis. British journal of clinical pharmacology 89(7) 2254–2262. DOI:10.1111/bcp.15697 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36811146

  2. Medellín-Garibay, SE, et al., & García, B (2022). Amikacin pharmacokinetics in elderly patients with severe infections. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 175 106219–None. DOI:10.1016/j.ejps.2022.106219 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35618200

  3. Bressolle, F, et al., & Gomeni, R (1996). Population pharmacokinetics of amikacin in critically ill patients. Antimicrobial agents and chemotherapy 40(7) 1682–1689. DOI:10.1128/AAC.40.7.1682 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8807062

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)